See other companies on Welcome to the Jungle
Trial Library
Oncology clinical trials
- 1-20 employees
- Healthcare
- B2B
- SaaS
- Social Impact
- Community
- MedTech
- Lower Pacific Heights, San Francisco, CA
Jump to section
Company mission
To improve health equity by expanding access to cancer precision medicine.
Few candidates hear
back within 2 weeks
Our take
Participation in clinical trials is limited, and requires both knowledge of them, and the availability and resources to proceed. As such, it has tended to freeze out a number of key groups who go on to be underrepresented in medical research - especially when it comes to cancer treatments. Public benefit company Trial Library wants to change this.
Trial Library promises to be a platform offering oncology clinicians sponsored opportunities to assess their patients for trial suitability. If successful, the platform will then help patients access resources for the trickier attendance logistics, like travel, food, and other services.
Having come out of stealth just recently, Trial Library is not yet operational - but it’s attracted some strong initial funding to get there. More importantly, it could prove a relatively distinctive offering in a growing field of companies tackling the trial diversity issue.
Startups like Acclinate, Antidote, and SubjectWell help researchers and pharmaceutical companies engage directly with underrepresented communities to advertise trials, whereas Trial Library appears to be more of an assistive tool for clinicians. The addition of logistics resources is a distinctive touch, too, but may need to be fleshed out to pull over customers from better-established rivals.
Steph
Company Specialist at Welcome to the Jungle
Benefits
- We are a remote-based, fast growth team
- All full-time employees receive paid vacation and parental leave
- We offer technology tools and a work-from-home setup stipend
- We offer medical, dental, and vision coverage to our employees
- We value career development for all
Company values
- Ally is our favorite moniker
- The most inclusive approach is worth the work
- Celebrate measurable improvements in equity outcomes
- Fearless advocates for diversity
- Incentives matter to stakeholders choosing our products
- Taking initiative is actually giving
- We are accountable for the experience of patients and providers
- Empathy and humility are the real dynamic duo
Funding (1 round)
Aug 2022
$5m
SEED
Total funding: $5m
This company has top investors
Leadership
Hala Borno
(CPO)A practicing medical Oncologist and Health Equity Researcher at the University of California, San Francisco, where she is also Lead of the Recruitment Science Research Hub.
Stephen Buck
(Co-founder)Previously the Director of American Express, then Visa USA, before spending time as VP of McKesson. Went on to found RxDividends, GoodRx, and Courage Health, and serve as VP/DM of Ro Pharmacy.